The efficacy and acceptability of anti-inflammatory omega-3 polyunsaturated fatty acid supplements in sepsis management: a network meta-analysis of randomized controlled trials
Prostaglandins, Leukotrienes and Essential Fatty Acids · 2024
DOI: 10.1016/j.plefa.2024.102633 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2024. Verfasst von Ping-Tao Tseng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Psychology, College of Medical and Health Science…. Hauptthemen laut MEDLINE: Dietary Supplements, Fatty Acids, Omega-3, Sepsis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Ministry of Education, National Institute for Health and Care Research, China Medical University Hospital.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a critical medical condition associated with high mortality for patients. Current pharmacological strategies for sepsis management or prevention had not achieved satisfactory results. The omega-3 fatty acids, with anti-inflammatory benefits, are considered to be promising agents for sepsis management/prevention. The aim of this network meta-analysis (NMA) is to compare the efficacy of various dosages and formulations of fish oil supplements for sepsis management and sepsis prevention. The current NMA consisted of two parts: (1) sepsis management and (2) sepsis prevention. The PubMed, ClinicalKey, Embase, ProQuest, Cochrane CENTRAL, ScienceDirect, Web of Science, and ClinicalTrials.gov databases were systematically searched to date of February 22nd, 2024 for relevant randomized controlled trials (RCTs). RCTs were eligible for inclusion if they enrolled participants with a diagnosis of sepsis or who with high risk for sepsis. All NMA procedures were conducted under the frequentist model. The primary outcomes assessed are (1) mortality rate in sepsis treatment or (2) incidence of sepsis in sepsis prevention. Our NMA, based on 28 RCTs and 1718 participants (mean age=51.6 years, mean female proportion=35.6 %), showed that (1) high dose parenteral fish oil supplement yield the lowest mortality rate in sepsis management in adult patients, and (2) high dose enteral fish oil supplement yield the lowest incidence of sepsis in pediatric patients. This study provides compelling evidence that high-dose fish oil supplements provide beneficial effects for both sepsis management and sepsis prevention. Our findings provide a preliminary rationale for future large-scale RCTs to investigate the role of fish oil supplementation in sepsis management or prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Psychology, College of Medical and Health Science, Asia University, Taichung, Taiwan; Prospect Clinic for Otorhinolaryn…
- Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Internal Medicine, E-Da Dachang Hospital, I-Shou University, Kaohsiung, Taiwan.
- Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Internal Medicine, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
- Department of Psychology, College of Medical and Health Science, Asia University, Taichung, Taiwan; Clinical Psychology Center, Asia University Hospital, Taichung, Taiwan.
- Institute of Psychiatry, King's College London, London, UK; Physiotherapy Department, South London and Maudsley NHS Foundation Trust, London, UK; Faculty of Health, Social Care Medicine and Education, Anglia Ruskin Univ…
- Neuroscience and Brain Disease Center, China Medical University, Taichung, Taiwan; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Förderung
- Ministry of Education
- National Institute for Health and Care Research
- China Medical University Hospital
- King's College London
- National Health Research Institutes
- Tainan Municipal An-Nan Hospital
- Maudsley Charity
- China Medical University
Zitieren
APA
Tseng, P. T., Zeng, B. Y., Zeng, B. S., Yeh, P. Y., Stubbs, B., Kuo, J. S., Sun, C. K., Cheng, Y. S., Chen, Y. W., Chen, T. Y., Wu, Y. C., Tu, Y. K., Lin, P. Y., Li, D. J., Liang, C. S., Suen, M. W., Lee, Y. C., Yang, W. C., Hsu, C. W., …, & Su, K. P. (2024). The efficacy and acceptability of anti-inflammatory omega-3 polyunsaturated fatty acid supplements in sepsis management: a network meta-analysis of randomized controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids. https://doi.org/10.1016/j.plefa.2024.102633
Vancouver
Tseng PT, Zeng BY, Zeng BS, Yeh PY, Stubbs B, Kuo JS, et al. The efficacy and acceptability of anti-inflammatory omega-3 polyunsaturated fatty acid supplements in sepsis management: a network meta-analysis of randomized controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2024. doi:10.1016/j.plefa.2024.102633
BibTeX
@article{Tseng2024,
author = {Tseng, Ping-Tao and Zeng, Bing-Yan and Zeng, Bing-Syuan and Yeh, Pin-Yang and Stubbs, Brendon and Kuo, John S and Sun, Cheuk-Kwan and Cheng, Yu-Shian and Chen, Yen-Wen and Chen, Tien-Yu and Wu, Yi-Cheng and Tu, Yu-Kang and Lin, Pao-Yen and Li, Dian-Jeng and Liang, Chih-Sung and Suen, Mein-Woei and Lee, Yi-Che and Yang, Wei-Chieh and Hsu, Chih-Wei and Shiue, Yow-Ling and Su, Kuan-Pin},
title = {The efficacy and acceptability of anti-inflammatory omega-3 polyunsaturated fatty acid supplements in sepsis management: a network meta-analysis of randomized controlled trials},
journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
year = {2024},
doi = {10.1016/j.plefa.2024.102633}
}
EUVIMED